This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).
- Investigator
- Carolina B Maciel
- Status
- Accepting Candidates
- Ages
- 12 Years - N/A
- Sexes
- All